SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against GERON CORPORATION and Its Board of Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action 
Against GERON CORPORATION and Its Board of Directors and a
Lead Plaintiff Deadline of May 13, 2014 -- GERN 
NEW YORK, NY -- (Marketwired) -- 03/20/14 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the Northern District of California
on behalf of investors who purchased Geron Corporation ("Geron" or
the "Company") (NASDAQ: GERN) common stock between June 16, 2013 to
March 11, 2014. 
For more information, click here: http://zlk.9nl.com/geron-gern. 
The complaint alleges that Geron misrepresented and/or failed to
disclose that: (a) persistent low-grade liver function test
abnormalities had been observed in the Phase 2 study of its drug
imetelstat in essential thrombocythemia or polycythemia vera
patients; (b) there was a high risk of potential chronic liver injury
following long-term exposure to the drug, and (c) as a result of the
foregoing, defendants' positive statements about the prospects for
imetelstat lacked a reasonable basic and/or were materially false and
misleading. 
On March 12, 2014, the Company announced it had received a verbal
notice from the U.S. Food and Drug Administration ("FDA") that its
Investigational New Drug (IND) application for imetelstat had been
placed on full clinical hold. On this news, shares of Geron stock
plunged over 60% to close at $1.69 per share, on extremely heavy
volume. 
If you suffered a loss in Geron you have until May 13, 2014 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at (212)
363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/geron-gern.  
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 
 
 
Press spacebar to pause and continue. Press esc to stop.